<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>401</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>14769915</PubmedId>
            <Abstract>The cytokine thrombopoietin (TPO), the ligand for the hematopoietic receptor c-Mpl, acts as a primary regulator of megakaryocytopoiesis and platelet production. We have determined the crystal structure of the receptor-binding domain of human TPO (hTPO(163)) to a 2.5-A resolution by complexation with a neutralizing Fab fragment. The backbone structure of hTPO(163) has an antiparallel four-helix bundle fold. The neutralizing Fab mainly recognizes the C-D crossover loop containing the species invariant residue Q111. Titration calorimetric experiments show that hTPO(163) interacts with soluble c-Mpl containing the extracellular cytokine receptor homology domains with 1:2 stoichiometry with the binding constants of 3.3 x 10(9) M(-1) and 1.1 x 10(6) M(-1). The presence of the neutralizing Fab did not inhibit binding of hTPO(163) to soluble c-Mpl fragments, but the lower-affinity binding disappeared. Together with prior genetic data, these define the structure-function relationships in TPO and the activation scheme of c-Mpl.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>1816-21</ArticlePages>
            <ArticleTitle>Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Feese</LastName>
                    <ForeName>Michael D</ForeName>
                </Author>
                <Author>
                    <LastName>Tamada</LastName>
                    <ForeName>Taro</ForeName>
                </Author>
                <Author>
                    <LastName>Kato</LastName>
                    <ForeName>Yoichi</ForeName>
                </Author>
                <Author>
                    <LastName>Maeda</LastName>
                    <ForeName>Yoshitake</ForeName>
                </Author>
                <Author>
                    <LastName>Hirose</LastName>
                    <ForeName>Masako</ForeName>
                </Author>
                <Author>
                    <LastName>Matsukura</LastName>
                    <ForeName>Yasuko</ForeName>
                </Author>
                <Author>
                    <LastName>Shigematsu</LastName>
                    <ForeName>Hideki</ForeName>
                </Author>
                <Author>
                    <LastName>Muto</LastName>
                    <ForeName>Takanori</ForeName>
                </Author>
                <Author>
                    <LastName>Matsumoto</LastName>
                    <ForeName>Atsushi</ForeName>
                </Author>
                <Author>
                    <LastName>Watarai</LastName>
                    <ForeName>Hiroshi</ForeName>
                </Author>
                <Author>
                    <LastName>Ogami</LastName>
                    <ForeName>Kinya</ForeName>
                </Author>
                <Author>
                    <LastName>Tahara</LastName>
                    <ForeName>Tomoyuki</ForeName>
                </Author>
                <Author>
                    <LastName>Kato</LastName>
                    <ForeName>Takashi</ForeName>
                </Author>
                <Author>
                    <LastName>Miyazaki</LastName>
                    <ForeName>Hiroshi</ForeName>
                </Author>
                <Author>
                    <LastName>Kuroki</LastName>
                    <ForeName>Ryota</ForeName>
                </Author>
            </Authors>
            <Affiliations>Central Laboratories for Key Technology, Kirin Brewery Co. Ltd., 1-13-5 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.</Affiliations>
            <ArticleChemicalList>Epitopes;Immunoglobulin Fab Fragments;Neoplasm Proteins;Proto-Oncogene Proteins;Receptors, Cytokine;Receptors, Thrombopoietin;MPL protein, human;Thrombopoietin</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Crystallography, X-Ray; Epitopes(chemistry; immunology); Humans; Immunoglobulin Fab Fragments(immunology; metabolism); Models, Molecular; Molecular Sequence Data; Neoplasm Proteins(metabolism); Neutralization Tests; Protein Binding; Protein Conformation; Proto-Oncogene Proteins(metabolism); Receptors, Cytokine(metabolism); Receptors, Thrombopoietin; Solubility; Structure-Activity Relationship; Substrate Specificity; Thrombopoietin(chemistry; immunology; metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>101</Volume>
                <Issue>7</Issue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <Issn>0027-8424</Issn>
                <MedlineTa>Proc Natl Acad Sci U S A</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>mAb TN1 epitope on Thrombopoietin (hTPO163)</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>E78, T79, K80, A81, Q82, R119, G123, A124, L125, Q126, S127, L128, L129, G130, T131, Q132, L133, P134, P135, R136;</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>P40225.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Text p. 1819 and PDB 1V7M</LocationOfData>
                <EpitopeId>127518</EpitopeId>
                <ReferenceRegion>E57, T58, K59, A60, Q61, R98, G102, A103, L104, Q105, S106, L107, L108, G109, T110, Q111, L112, P113, P114, R115;</ReferenceRegion>
                <EpitopeEvidenceCode>Author provided Identifier</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Tables 1 and 2 and Figures 1, 2, 3 and PDB 1V7N</LocationOfData>
                        <BCellId>1650226</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P40225.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>recombinant hTPO</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody TN-1 was previously described in the reference cited: Tahara et al. (1998) Stem Cells 16: 54-60 [PMID: 9474748].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.3</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope was determined from the crystal structure of Fab TN1 bound to the receptor-binding domain of human TPO. There are four molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : Antibody heavy-chain: H, Antibody light-chain: L, epitope chain: V. Complex II : Antibody heavy-chain: I, Antibody light-chain: M, epitope chain: X. Complex III : Antibody heavy-chain: J, Antibody light-chain: N, epitope chain: Y.  Complex IV : Antibody heavy-chain: K, Antibody light-chain: O, epitope chain: Z. The crystal structure belongs to space group P21. In the epitope molecule, residues 1-6 and 152-163 could not be distinguished in electron density maps and were omitted from the model.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>TN1-neutralizing</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>TN1</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1V7M_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1V7M_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>hTPO 163</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SPAPPACDLRVLSKLLRDSHVLHSRLSQCPEVHPLPTPVLLPAVDFSLGEWKTQMEETKAQDILGAVTLLLEGVMAARGQLGPTCLSSLLGQLSGQVRLLLGALQSLLGTQLPPQGRTTAHKDPNAIFLSFQHLLRGKVRFLMLVGGSTLCVRRAPPTTAVPS</LinearSequence>
                                        <StartingPosition>22</StartingPosition>
                                        <EndingPosition>184</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P40225.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1V7N</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>V</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>Conformational comparison of TN1-neutralizing Fab/hTPO in space group P21 (this structure) and the same complex in space group C2 [PDB: 1V7M] showed that the two structures are nearly identical.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>V: E57, T58, K59, A60, Q61, R98, G102, A103, L104, Q105, S106, L107, L108, G109, T110, Q111, L112, P113, P114, R115;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: ; L: ;</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>799.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>777.0</ContactAreaForAntibody>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>V: E57, T58, Q61, L71, R98, G102, Q105, S106, G109, T110, Q111, L112, P113, R115</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: T28, D31, A32, W33, S53, V55, N56, W101, S102; L: S30, Y31, Y33, Y48, S49, N52, R90, Y93, R95</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>749.8</ContactAreaForAntigen>
                                <ContactAreaForAntibody>746.8</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 3 and text p. 1820</LocationOfData>
                        <BCellId>1755178</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P40225.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>recombinant hTPO</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody TN-1 was previously described in the reference cited: Tahara et al. (1998) Stem Cells 16: 54-60 [PMID: 9474748].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>243</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.0</QuantitativeMeasurement>
                            <AssayComments>The binding of epitope-specific Fab TN1 to fragment hTPO 1-163 occluded the low affinity binding site on the c-Mpl receptor, as measured by isothermal titration calorimetry. The association constant of hTPO 163 and TN1 is about 1 nM, whereas, that of c-Mpl at the low affinity site is about 1 ÂµM, explaining the strong neutralizing activity of TN1.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>TN1-neutralizing</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>TN1</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1V7M_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1V7M_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>hTPO 163</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SPAPPACDLRVLSKLLRDSHVLHSRLSQCPEVHPLPTPVLLPAVDFSLGEWKTQMEETKAQDILGAVTLLLEGVMAARGQLGPTCLSSLLGQLSGQVRLLLGALQSLLGTQLPPQGRTTAHKDPNAIFLSFQHLLRGKVRFLMLVGGSTLCVRRAPPTTAVPS</LinearSequence>
                                        <StartingPosition>22</StartingPosition>
                                        <EndingPosition>184</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P40225.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Tables 1 and 2 and Figures 1, 2, 3 and PDB 1V7M</LocationOfData>
                        <BCellId>1650227</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P40225.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>recombinant hTPO</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody TN-1 was previously described in the reference cited: Tahara et al. (1998) Stem Cells 16: 54-60 [PMID: 9474748].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.5</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope was determined from the crystal structure of Fab TN1 bound to the receptor-binding domain of human TPO. There are two molecules in the crystallographic asymmetric unit. PDB chains for each complex are: Complex I : Antibody heavy-chain: H, Antibody light-chain: L, epitope chain: V. Complex II : Antibody heavy-chain: I, Antibody light-chain: M, epitope chain: X.The crystal structure belongs to space group C2.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>TN1-neutralizing</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>TN1</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1V7M_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1V7M_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>hTPO 163</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SPAPPACDLRVLSKLLRDSHVLHSRLSQCPEVHPLPTPVLLPAVDFSLGEWKTQMEETKAQDILGAVTLLLEGVMAARGQLGPTCLSSLLGQLSGQVRLLLGALQSLLGTQLPPQGRTTAHKDPNAIFLSFQHLLRGKVRFLMLVGGSTLCVRRAPPTTAVPS</LinearSequence>
                                        <StartingPosition>22</StartingPosition>
                                        <EndingPosition>184</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P40225.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1V7M</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>V</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>Conformational comparison of TN1-neutralizing Fab/hTPO in space group C2 (this structure) and the same complex in space group P21 [PDB: 1V7N] showed that the two structures are nearly identical.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>V: E57, T58, K59, A60, Q61, R98, G102, A103, L104, Q105, S106, L107, L108, G109, T110, Q111, L112, P113, P114, Q115;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: ; L: ;</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>799.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>777.0</ContactAreaForAntibody>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>V: E57, T58, Q61, T68, L71, M75, R98, G102, Q105, S106, G109, T110, Q111, L112, P113, P114, Q115</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: T28, D31, A32, W33, V55, N56, W101, S102, L104; L: S30, Y31, Y33, Y48, S49, R90, Y93, R95</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>768.3</ContactAreaForAntigen>
                                <ContactAreaForAntibody>779.0</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

